On September 29th, 2014, Insys Therapeutics announced that the United States Food and Drug Administration had granted orphan drug designation to its proprietary cannabidiol product for the treatment of glioma. … Continue reading FDA Approves Cannabis For Brain Cancer Treatment (Kinda)